Courtney Perry

7PUBLICATIONS
17CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Intensive careSocial epidemiologyMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 27, 2025
Dual Biologic Therapy Induces Remission in Refractory Crohn's Disease With Vedolizumab and Ustekinumab.

Syed Adeel Hassan, Courtney Perry, Patrick Carey

|Jan 26, 2024
Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter Experience.

Jeffrey A Berinstein, Taylor Karl, Anish Patel

|Jun 06, 2023
Inflammatory Bowel Disease in Appalachian Kentucky: An Investigation of Outcomes and Health Care Utilization.

Christian N Rhudy, Courtney L Perry, Gregory S Hawk

|Feb 13, 2023
Bezlotoxumab Therapy for Recurrent Clostridium difficile Infection in an Ulcerative Colitis Patient.

Aaron Fein, Cody Kern, Terrance Barrett

|Jul 26, 2020
Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative Colitis.

Courtney Perry, Kyle Fischer, Ahmed Elmoursi

Pageof 2